Baidu
map

已致31人死亡!缅甸甲型H1N1流感疫情严重

2019-07-10 佚名 新华网

据缅甸卫生和体育部最新公布的数据,自今年6月以来,缅甸全国已有180人确认感染甲型H1N1流感病毒,其中31人死亡。卫生和体育部通报说,此次甲型H1N1流感疫情影响缅甸多个省邦,从6月1日至7月9日,已累计报告180例感染病例,其中仰光省病例数最多,达到108人,致死25人。自2009年以来,甲型H1N1流感疫情已多次在缅甸出现。2017年,缅甸全国有400多人感染此型流感病毒,致数十人死亡。甲型

据缅甸卫生和体育部最新公布的数据,自今年6月以来,缅甸全国已有180人确认感染甲型H1N1流感病毒,其中31人死亡。

卫生和体育部通报说,此次甲型H1N1流感疫情影响缅甸多个省邦,从6月1日至7月9日,已累计报告180例感染病例,其中仰光省病例数最多,达到108人,致死25人。

自2009年以来,甲型H1N1流感疫情已多次在缅甸出现。2017年,缅甸全国有400多人感染此型流感病毒,致数十人死亡。

甲型H1N1流感是一种急性传染性呼吸系统疾病,其症状为突发咳嗽、呼吸困难、发热等,病情严重者会出现继发性肺炎、甚至死亡。这种流感病毒传染性强,秋冬季高发,可全年传播。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1764372, encodeId=dc761e6437225, content=<a href='/topic/show?id=e7b069e6635' target=_blank style='color:#2F92EE;'>#甲型H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69766, encryptionId=e7b069e6635, topicName=甲型H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514c37720126, createdName=passed water, createdTime=Thu Oct 24 13:57:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664550, encodeId=5f6a1664550d1, content=<a href='/topic/show?id=c5c665333d3' target=_blank style='color:#2F92EE;'>#流感疫情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65333, encryptionId=c5c665333d3, topicName=流感疫情)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509225785471, createdName=ms7421025882867189, createdTime=Sun Dec 01 10:57:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469532, encodeId=9f5b14695323f, content=<a href='/topic/show?id=d46a83e3d8' target=_blank style='color:#2F92EE;'>#H1N1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8373, encryptionId=d46a83e3d8, topicName=H1N1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee77038498, createdName=TZF0806, createdTime=Fri Jul 12 11:57:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631373, encodeId=736a16313e3e0, content=<a href='/topic/show?id=fda383e43b' target=_blank style='color:#2F92EE;'>#H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8374, encryptionId=fda383e43b, topicName=H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eee21750483, createdName=apoenzyme, createdTime=Fri Jul 12 11:57:00 CST 2019, time=2019-07-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1764372, encodeId=dc761e6437225, content=<a href='/topic/show?id=e7b069e6635' target=_blank style='color:#2F92EE;'>#甲型H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69766, encryptionId=e7b069e6635, topicName=甲型H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514c37720126, createdName=passed water, createdTime=Thu Oct 24 13:57:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664550, encodeId=5f6a1664550d1, content=<a href='/topic/show?id=c5c665333d3' target=_blank style='color:#2F92EE;'>#流感疫情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65333, encryptionId=c5c665333d3, topicName=流感疫情)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509225785471, createdName=ms7421025882867189, createdTime=Sun Dec 01 10:57:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469532, encodeId=9f5b14695323f, content=<a href='/topic/show?id=d46a83e3d8' target=_blank style='color:#2F92EE;'>#H1N1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8373, encryptionId=d46a83e3d8, topicName=H1N1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee77038498, createdName=TZF0806, createdTime=Fri Jul 12 11:57:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631373, encodeId=736a16313e3e0, content=<a href='/topic/show?id=fda383e43b' target=_blank style='color:#2F92EE;'>#H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8374, encryptionId=fda383e43b, topicName=H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eee21750483, createdName=apoenzyme, createdTime=Fri Jul 12 11:57:00 CST 2019, time=2019-07-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1764372, encodeId=dc761e6437225, content=<a href='/topic/show?id=e7b069e6635' target=_blank style='color:#2F92EE;'>#甲型H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69766, encryptionId=e7b069e6635, topicName=甲型H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514c37720126, createdName=passed water, createdTime=Thu Oct 24 13:57:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664550, encodeId=5f6a1664550d1, content=<a href='/topic/show?id=c5c665333d3' target=_blank style='color:#2F92EE;'>#流感疫情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65333, encryptionId=c5c665333d3, topicName=流感疫情)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509225785471, createdName=ms7421025882867189, createdTime=Sun Dec 01 10:57:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469532, encodeId=9f5b14695323f, content=<a href='/topic/show?id=d46a83e3d8' target=_blank style='color:#2F92EE;'>#H1N1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8373, encryptionId=d46a83e3d8, topicName=H1N1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee77038498, createdName=TZF0806, createdTime=Fri Jul 12 11:57:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631373, encodeId=736a16313e3e0, content=<a href='/topic/show?id=fda383e43b' target=_blank style='color:#2F92EE;'>#H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8374, encryptionId=fda383e43b, topicName=H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eee21750483, createdName=apoenzyme, createdTime=Fri Jul 12 11:57:00 CST 2019, time=2019-07-12, status=1, ipAttribution=)]
    2019-07-12 TZF0806
  4. [GetPortalCommentsPageByObjectIdResponse(id=1764372, encodeId=dc761e6437225, content=<a href='/topic/show?id=e7b069e6635' target=_blank style='color:#2F92EE;'>#甲型H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69766, encryptionId=e7b069e6635, topicName=甲型H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514c37720126, createdName=passed water, createdTime=Thu Oct 24 13:57:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664550, encodeId=5f6a1664550d1, content=<a href='/topic/show?id=c5c665333d3' target=_blank style='color:#2F92EE;'>#流感疫情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65333, encryptionId=c5c665333d3, topicName=流感疫情)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509225785471, createdName=ms7421025882867189, createdTime=Sun Dec 01 10:57:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469532, encodeId=9f5b14695323f, content=<a href='/topic/show?id=d46a83e3d8' target=_blank style='color:#2F92EE;'>#H1N1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8373, encryptionId=d46a83e3d8, topicName=H1N1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee77038498, createdName=TZF0806, createdTime=Fri Jul 12 11:57:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631373, encodeId=736a16313e3e0, content=<a href='/topic/show?id=fda383e43b' target=_blank style='color:#2F92EE;'>#H1N1流感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8374, encryptionId=fda383e43b, topicName=H1N1流感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eee21750483, createdName=apoenzyme, createdTime=Fri Jul 12 11:57:00 CST 2019, time=2019-07-12, status=1, ipAttribution=)]

相关资讯

波兰“甲流”又致2人死亡

  新华网华沙1月7日电(记者韩梅)据波兰媒体7日报道,波兰甲型H1N1流感疫情今年已致2人死亡。   报道说,波兰克拉科夫市今年已确诊两例因感染甲型H1N1流感病毒而死亡的病例。同时在克拉科夫的临近省西里西亚省、西滨海省以及瓦尔米亚-马祖里省也发现并确诊有10多人已感染甲型H1N1流感病毒。   据克拉科夫所在的小波兰省卫生防疫站介绍,在克拉科夫死亡的2人年龄均为50岁。   2012年波

甲型H1N1流感患者的影像学及临床特点

河北医科大学第二医院呼吸科安聪静和阎锡新分析探讨了新型甲型H1N1流感确诊病例的影像学变化及临床特点,结果发现,甲型流感重症及危重症病例影像学呈磨玻璃和实变密度的片状阴影改变,以双肺受累常见,主要分布于中下肺,肺野中外1/3及胸膜下。胸部影像学不但是诊断甲型H1N1流感的重要依据,也是监测其病情变化,评价治疗效果及预后的重要手段。相关论文发表于2013年第2期《中华实验和临床感染病杂志》。 研究

挪威甲流病例呈上升趋势

  据挪威《世界之路报》31日报道,挪威各地近期确诊的甲型H1N1流感病例呈上升趋势,估计在2013年1月达到高峰。     报道说,位于奥斯陆附近的阿克什胡斯大学医院近两周已接诊84例甲型H1N1流感病例,挪威西南部的斯塔万格大学医院接诊病例3例(其中1人处于重症监护状态),挪威中部港口城市特隆赫姆一医院确诊甲型H1N1流感病人1名,挪威西部港口城市卑尔根一医院收治14名疑似甲型H1N1流感病

美甲型H1N1流感已致13人死亡

美国疾病预防和控制中心(CDC)专家警告,随着南部多州感染甲型H1N1流感病毒人群激增,美国新一轮流感季到来,目前已造成得克萨斯州大休斯敦地区13人死亡。与以往流感病毒主要威胁幼儿和老年人不同,今年年轻的成年人和中年人成为高危人群。 据疾控中心统计,最近一周来,报告流感发病率超过往年的州,从之前的得克萨斯、路易斯安那、亚拉巴马和密西西比4个州一下子跃升至10个州。“这意味着美国已经进入典

PLoS Pathog:王辰、曹彬教授团队揭示奥司他韦联合西罗莫司治疗重症流感的机制

2018年11月,首都医科大学中日友好医院王辰、曹彬教授团队在病毒学顶级专业杂志《PLoS Pathogens》(IF:6.957)上发表题为「Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 in

Baidu
map
Baidu
map
Baidu
map